Medanta Global Health Limited (NSE: Medanta, BSE: 543654) has expanded its presence in North India with the launch of a 550-bed super-specialty hospital in Noida, bringing advanced healthcare closer to patients. Operational since September 2025 with 226 beds, 81 ICU beds, and five operating theatres, the hospital has already onboarded 151 doctors and features cutting-edge medical technology to provide high-quality care.
For Q2 FY2026, Medanta reported consolidated total income of INR 11,189 million, up 14.8% year-on-year, with net profit increasing 21.1% to INR 1,584 million. EBITDA excluding Noida rose 13.7% to INR 2,804 million. Mature hospitals generated INR 7,200 million in revenue, while developing hospitals excluding Noida grew 28.3%, reflecting growing demand. International patient revenue surged 48.5% to INR 762 million, and OPD pharmacy revenue rose 23.9% to INR 456 million, showing strong uptake of Medanta’s services.
Medanta is exploring expansion opportunities to make advanced tertiary care more accessible. Strategic site evaluation and partnerships aim to serve local patients and neighboring communities, improving access to specialized medical services previously limited in the region. Additional developments include capacity expansions in Patna and Lucknow, as well as the upcoming 500–750 bed hospital in Mumbai, reflecting Medanta’s ongoing commitment to bringing healthcare closer to communities across India.
